The Reply
- PMID: 33962708
- PMCID: PMC8095713
- DOI: 10.1016/j.amjmed.2021.01.011
The Reply
Figures
Comment on
-
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7. Am J Med. 2021. PMID: 32771461 Free PMC article. Review.
-
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19.Am J Med. 2021 May;134(5):e341-e342. doi: 10.1016/j.amjmed.2021.01.004. Am J Med. 2021. PMID: 33962707 Free PMC article. No abstract available.
References
-
- McCullough PA, Alexander PE, Armstrong R, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) Rev Cardiovasc Med. 2020;21(4):517–530. - PubMed
-
- Procter BC, Ross C, Pickard V, Smith E, Hanson C, McCullough PA. Early ambulatory multidrug therapy reduces hospitalization and death in high-risk patients with SARS-CoV-2 (COVID-19) [e-pub ahead of print]. Authorea. doi:10.22541/au.161000355.54720791/v1, Accessed January 15, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
